← All trials
NCT05744427
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2023
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2025
- First posted
- Feb 27, 2023
- Last posted
- Jul 17, 2023
- Enrollment
- 300
- Arms / groups
- 7 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Alphamab Co., Ltd.Lead sponsor
- Peking UniversityOverall official - principal investigator
- Peking UniversityOfficial
- Sun Yat-Sen UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.